Display options
Cite
Chan Y, Mehta M, Paudel KR, et al. Versatility of liquid crystalline nanoparticles in inflammatory lung diseases. Nanomedicine (Lond). 2021;16(18):1545-1548doi: 10.2217/nnm-2021-0114.
Chan, Y., Mehta, M., Paudel, K. R., Madheswaran, T., Panneerselvam, J., Gupta, G., Su, Q. P., Hansbro, P. M., MacLoughlin, R., Dua, K., & Chellappan, D. K. (2021). Versatility of liquid crystalline nanoparticles in inflammatory lung diseases. Nanomedicine (London, England), 16(18), 1545-1548. https://doi.org/10.2217/nnm-2021-0114
Chan, Yinghan, et al. "Versatility of liquid crystalline nanoparticles in inflammatory lung diseases." Nanomedicine (London, England) vol. 16,18 (2021): 1545-1548. doi: https://doi.org/10.2217/nnm-2021-0114
Chan Y, Mehta M, Paudel KR, Madheswaran T, Panneerselvam J, Gupta G, Su QP, Hansbro PM, MacLoughlin R, Dua K, Chellappan DK. Versatility of liquid crystalline nanoparticles in inflammatory lung diseases. Nanomedicine (Lond). 2021 Aug;16(18):1545-1548. doi: 10.2217/nnm-2021-0114. Epub 2021 Jun 29. PMID: 34184917.
Copy Download .nbib Format: NLM
Share it on

Nanomedicine (Lond). 2021 Aug;16(18):1545-1548. doi: 10.2217/nnm-2021-0114. Epub 2021 Jun 29.

Versatility of liquid crystalline nanoparticles in inflammatory lung diseases.

Nanomedicine (London, England)

Yinghan Chan, Meenu Mehta, Keshav Raj Paudel, Thiagarajan Madheswaran, Jithendra Panneerselvam, Gaurav Gupta, Qian Peter Su, Philip Michael Hansbro, Ronan MacLoughlin, Kamal Dua, Dinesh Kumar Chellappan

Affiliations

  1. School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia.
  2. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW, 2007, Australia.
  3. Centre for Inflammation, Centenary Institute, Sydney, NSW, 2050, Australia.
  4. School of Life Sciences, University of Technology Sydney, Ultimo, NSW, 2007, Australia.
  5. Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia.
  6. School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur, 302017, India.
  7. School of Biomedical Engineering, Faculty of Engineering & Information Technology, University of Technology Sydney, Sydney, NSW, 2007, Australia.
  8. Aerogen, IDA Business Park, Dangan, Galway, H91 HE94, Ireland.
  9. School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland.
  10. School of Pharmacy & Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland.
  11. Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, 57000, Malaysia.

PMID: 34184917 DOI: 10.2217/nnm-2021-0114

[No abstract available.]

Keywords: drug delivery; inflammation; liquid crystalline nanoparticles; lung disease

MeSH terms

Publication Types